Brazil Nuclear Imaging Market Overview in 2025

• Market Size in 2024: USD 332 Million
• Market Forecast in 2033: USD 446 Million
• Market Growth Rate 2025-2033: 3.30%

The Brazil nuclear imaging market was valued at USD 332 million in 2024 and is projected to reach USD 446 million by 2033, growing at a CAGR of 3.30%. Expanding cardiac and oncology applications, together with gradual reimbursement improvements, are driving robust demand for SPECT and PET modalities.

Growth Drivers for Brazil Nuclear Imaging Market

SUS Expands PET-CT Reimbursement for Prostate Cancer

In January 2024, Brazil’s Unified Health System added 18F-PSMA PET-CT to the approved procedure list for high-risk prostate cancer staging. The Ministry of Health forecasts 28,000 additional scans annually, prompting six public hospitals in São Paulo and Rio de Janeiro to install new PET-CT suites. The policy widens patient access and directly boosts radiopharmaceutical uptake across the Brazil nuclear imaging market.

CNEN Streamlines Radioisotope Import Permits to Ten Days

The National Nuclear Energy Commission reduced import licence turnaround from 45 to 10 business days in March 2024. Logistics data show that the average 18F-FDG delivery times shortened by 1.2 days, cutting cold-kit wastage by 15%. Faster approvals encourage private imaging centres to adopt just-in-time models, supporting volume growth in the Brazilian nuclear imaging market.

Local 99Mo Production Restart Set for 2025

The IEA-R1 multipurpose reactor at IPEN-CNEN/SP resumed refurbishment funding in 2023, with BRL 135 million earmarked for target irradiation upgrades. Once online, domestic 99Mo output will cover 40% of national demand, reducing reliance on South African imports. Stable technetium supply underpins scheduling reliability for cardiac SPECT, a key revenue generator for the Brazil nuclear imaging market.

Request a sample report: https://www.imarcgroup.com/Brazil-nuclear-imaging-market/requestsample

Brazil Nuclear Imaging Market Segmentation

Analysis by Product:

• Equipment
• Diagnostic Radioisotope
  • SPECT Radioisotopes
  • PET Radioisotopes

Analysis by Application:

• SPECT 
  • Cardiology
  • Neurology
  • Thyroid
  • Others
• PET 
  • Oncology
  • Cardiology
  • Neurology
  • Others

Regional Analysis:

• Southeast
• South
• Northeast
• North
• Central-West

Competitive Landscape

The competitive landscape of the industry has also been examined along with the profiles of the key players.

Brazil Nuclear Imaging Market News

• May 2024: Siemens Healthineers installs Brazil’s first high-sensitivity PET-MR system at Hospital Sírio-Libanês in São Paulo.
• April 2024: The National Agency of Supplementary Health mandates coverage of cardiac PET perfusion scans for private insurers, effective June 2024.
• March 2024: IPEN signs a technology transfer agreement with an Argentine reactor to secure a backup 99Mo supply during scheduled maintenance.
• February 2024: Curium announces the launch of a next-generation 68Ga-DOTATATE kit for neuroendocrine tumour imaging, manufactured at its new Cotia facility.

Key highlights of the Report:

• Market Performance (2019-2024)
• Market Outlook (2025-2033)
• COVID-19 Impact on the Market
• Porter’s Five Forces Analysis
• Strategic Recommendations
• Historical, Current and Future Market Trends
• Market Drivers and Success Factors
• SWOT Analysis
• Structure of the Market
• Value Chain Analysis
• Comprehensive Mapping of the Competitive Landscape

Note: If you need specific information that is not currently within the scope of the report, we can provide it to you as part of the customization.

About Us:

IMARC Group is a global management consulting firm that helps the world’s most ambitious changemakers to create a lasting impact. The company provide a comprehensive suite of market entry and expansion services. IMARC offerings include thorough market assessment, feasibility studies, company incorporation assistance, factory setup support, regulatory approvals and licensing navigation, branding, marketing and sales strategies, competitive landscape and benchmarking analyses, pricing and cost research, and procurement research.